SEC Filing - Vanda Pharmaceuticals Inc.

View:

Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

VANDA PHARMACEUTICALS INC.

(Name of Issuer)

Common Stock, Par Value $0.001

(Title of Class of Securities)

921659108

(CUSIP Number)

May 27, 2009

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 10


CUSIP No. 921659108		13G		Page 2 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON S.A.C. Capital Advisors, L.P.
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 460,000 (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 460,000 (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 460,000 (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.7% (see Item 4)
12		TYPE OF REPORTING PERSON* PN

*SEE INSTRUCTION BEFORE FILLING OUT

Page 2 of 10


CUSIP No. 921659108		13G		Page 3 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON S.A.C. Capital Advisors, Inc.
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 460,000 (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 460,000 (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 460,000 (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.7% (see Item 4)
12		TYPE OF REPORTING PERSON* CO

*SEE INSTRUCTION BEFORE FILLING OUT

Page 3 of 10


CUSIP No. 921659108		13G		Page 4 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON CR Intrinsic Investors, LLC
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 500,000 (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 500,000 (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 500,000 (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.9% (see Item 4)
12		TYPE OF REPORTING PERSON* OO

*SEE INSTRUCTION BEFORE FILLING OUT

Page 4 of 10


CUSIP No. 921659108		13G		Page 5 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Sigma Capital Management, LLC
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 1,319,423 (1) (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 1,319,423 (1) (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,319,423 (1) (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% (1) (see Item 4)
12		TYPE OF REPORTING PERSON* OO

*SEE INSTRUCTION BEFORE FILLING OUT

Page 5 of 10


CUSIP No. 921659108		13G		Page 6 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Sigma Capital Associates, LLC
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION Anguilla, British West Indies


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 1,319,423 (1) (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 1,319,423 (1) (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,319,423 (1) (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% (1) (see Item 4)
12		TYPE OF REPORTING PERSON* OO

*SEE INSTRUCTION BEFORE FILLING OUT

Page 6 of 10


CUSIP No. 921659108		13G		Page 7 of 10 Pages


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Steven A. Cohen
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x
3		SEC USE ONLY
4		CITIZENSHIP OR PLACE OF ORGANIZATION United States


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5 SOLE VOTING POWER 0
		6 SHARED VOTING POWER 2,279,423 (1) (see Item 4)
		7 SOLE DISPOSITIVE POWER 0
		8 SHARED DISPOSITIVE POWER 2,279,423 (1) (see Item 4)


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,279,423 (1) (see Item 4)
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES		¨
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.6% (1) (see Item 4)
12		TYPE OF REPORTING PERSON* IN

*SEE INSTRUCTION BEFORE FILLING OUT

Page 7 of 10

Item 1

(a)

Name of Issuer:

Vanda Pharmaceuticals Inc.

Item 1

(b)

Address of Issuer’s Principal Executive Offices:

9605 Medical Center Drive, Suite 300, Rockville, Maryland 20850

Item 2

(a)

Name of Person Filing:

This statement is filed by: (i) S.A.C. Capital Advisors, L.P. (“SAC Capital Advisors LP”) with respect to shares of Common Stock, par value $0.001 (the “Shares”) of the Issuer beneficially owned by S.A.C. Capital Associates, LLC (“SAC Capital Associates”); (ii) S.A.C. Capital Advisors, Inc. (“SAC Capital Advisors Inc.”) with respect to Shares beneficially owned by SAC Capital Advisors LP and SAC Capital Associates; (iii) CR Intrinsic Investors, LLC (“CR Intrinsic Investors”) with respect to Shares beneficially owned by CR Intrinsic Investments, LLC (“CR Intrinsic Investments”); (iv) Sigma Capital Management, LLC (“Sigma Management”) with respect to Shares beneficially owned by Sigma Capital Associates, LLC (“Sigma Capital Associates”); (v) Sigma Capital Associates with respect to Shares beneficially owned by it; and (vi) Steven A. Cohen with respect to Shares beneficially owned by SAC Capital Advisors LP, SAC Capital Advisors Inc., SAC Capital Associates, CR Intrinsic Investors, CR Intrinsic Investments, Sigma Management, and Sigma Capital Associates.

SAC Capital Advisors LP, SAC Capital Advisors Inc., CR Intrinsic Investors, Sigma Management, Sigma Capital Associates, and Steven A. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

Item 2

(b)

Address or Principal Business Office:

The address of the principal business office of (i) SAC Capital Advisors LP, SAC Capital Advisors Inc., CR Intrinsic Investors and Mr. Cohen is 72 Cummings Point Road, Stamford, Connecticut 06902; (ii) Sigma Management is 540 Madison Avenue, New York, New York 10022; and (iii) Sigma Capital Associates is Victoria House, P.O. Box 58, The Valley, Anguilla, British West Indies.

Item 2

(c)

Citizenship:

SAC Capital Advisors LP is a Delaware limited partnership. SAC Capital Advisors Inc. is a Delaware corporation. CR Intrinsic Investors and Sigma Management are Delaware limited liability companies. Sigma Capital Associates is an Anguillan limited liability company. Mr. Cohen is a United States citizen.

Item 2

(d)

Title of Class of Securities:

Common Stock, par value $0.001

Item 2

(e)

CUSIP Number:

921659108

Item 3

Not Applicable

Page 8 of 10


Item 4		Ownership:

		The percentages used herein are calculated based upon the Shares issued and outstanding as of May 7, 2009 as reported on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission by the Issuer for the quarterly period ended March 31, 2009.

		As of the close of business on June 5, 2009:

		1. S.A.C. Capital Advisors, L.P.

		(a)		Amount beneficially owned:

				460,000

		(b)		Percent of class:

				1.7%

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						460,000

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						460,000

		2. S.A.C. Capital Advisors, Inc.

		(a)		Amount beneficially owned:

				460,000

		(b)		Percent of class:

				1.7%

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						460,000

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						460,000

		3. CR Intrinsic Investors, LLC

		(a)		Amount beneficially owned:

				500,000

		(b)		Percent of class:

				1.9%

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						500,000

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						500,000

		4. Sigma Capital Management, LLC

		(a)		Amount beneficially owned:

				1,319,423 (1)

		(b)		Percent of class:

				5.0% (1)

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						1,319,423 (1)

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						1,319,423 (1)

		5. Sigma Capital Associates, LLC

		(a)		Amount beneficially owned:

				1,319,423 (1)

		(b)		Percent of class:

				5.0% (1)

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						1,319,423 (1)

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						1,319,423 (1)

		6. Steven A. Cohen

		(a)		Amount beneficially owned:

				2,279,423 (1)

		(b)		Percent of class:

				8.6% (1)

		(c)		(i)		Sole power to vote or direct the vote:

						-0-

				(ii)		Shared power to vote or direct the vote:

						2,279,423 (1)

				(iii)		Sole power to dispose or direct the disposition:

						-0-

				(iv)		Shared power to dispose or direct the disposition:

						2,279,423 (1)
		(1) Includes 250,000 Shares subject to a call option held by Sigma Capital Associates.

		SAC Capital Advisors LP, SAC Capital Advisors Inc., CR Intrinsic Investors, Sigma Management and Mr. Cohen own directly no Shares. Pursuant to an investment management agreement, SAC Capital Advisors LP maintains investment and voting power with respect to the securities held by SAC Capital Associates. SAC Capital Advisors Inc. is the general partner of SAC Capital Advisors LP. Pursuant to an investment management agreement, CR Intrinsic Investors maintains investment and voting power with respect to the securities held by CR Intrinsic Investments. Pursuant to an investment management agreement, Sigma Management maintains investment and voting power with respect to the securities held by Sigma Capital Associates. Mr. Cohen controls each of SAC Capital Advisors Inc., CR Intrinsic Investors and Sigma Management. By reason of the provisions of Rule 13d-3 of the Securities Exchange Act of 1934, as amended, each of (i) SAC Capital Advisors LP, SAC Capital Advisors Inc. and Mr. Cohen may be deemed to beneficially own 460,000 Shares (constituting approximately 1.7% of the Shares outstanding); (ii) CR Intrinsic Investors and Mr. Cohen may be deemed to beneficially own 500,000 Shares (constituting approximately 1.9% of the Shares outstanding) and (iii) Sigma Management and Mr. Cohen may be deemed to beneficially own 1,319,423 (1) Shares (constituting approximately 5.0% (1) of the Shares outstanding). Each of SAC Capital Advisors LP, SAC Capital Advisors Inc., CR Intrinsic Investors, Sigma Management and Mr. Cohen disclaims beneficial ownership of any of the securities covered by this statement.

Item 5		Ownership of Five Percent or Less of a Class:

		If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ¨

Item 6		Ownership of More than Five Percent on Behalf of Another Person:

		Not Applicable

Item 7		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

		Not Applicable

Item 8		Identification and Classification of Members of the Group:

		Not Applicable

Item 9		Notice of Dissolution of Group:

		Not Applicable

Item 10		Certification:

		By signing below the signatory certifies that, to the best of his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 9 of 10

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 8, 2009


S.A.C. CAPITAL ADVISORS, L.P.

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

S.A.C. CAPITAL ADVISORS, INC.

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

CR INTRINSIC INVESTORS, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

SIGMA CAPITAL MANAGEMENT, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

SIGMA CAPITAL ASSOCIATES, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

STEVEN A. COHEN

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

Page 10 of 10

JOINT FILING AGREEMENT

Exhibit 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.

Dated: June 8, 2009


S.A.C. CAPITAL ADVISORS, L.P.

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

S.A.C. CAPITAL ADVISORS, INC.

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

CR INTRINSIC INVESTORS, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

SIGMA CAPITAL MANAGEMENT, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

SIGMA CAPITAL ASSOCIATES, LLC

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person

STEVEN A. COHEN

By:		/s/ Peter Nussbaum
Name:		Peter Nussbaum
Title:		Authorized Person